Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2012-11-22

Clinical Trial Update: Metacognitive Therapy for Comorbid Insomnia [NA]

View source ↗

Summary

The clinical trial evaluating metacognitive therapy for secondary insomnia was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Norwegian University of Science and Technology | Conditions: Secondary Insomnia | NA | Status: WITHDRAWN